The use of complementary and alternative medicine in patients with a urological malignancy

Choung Soo Kim, Sungchan Park, Sang Bok Lee, Jung Min Lee, Han Chung, Moon Kee Chung, Duck Ki Yoon, Jun Cheon, Wun Jae Kim, Byung Ha Chung, Sung Joon Hong, Jae Mann Song, Sung Goo Chang, Han Yong Choi, Joung Sik Rim, Yong Hyun Cho, Kyung Hyun Moon, Bup Wan Kim, Bup Wan Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: The use of complementary and alternative medicine (CAM) is very common among patients with a urological malignancy. We assessed the prevalence and patterns of use of complementary therapies among patients with bladder, prostate and renal cancers. Materials and Methods: Between May and July 2004, we conducted a survey to assess the use of CAM at 13 outpatient clinics in Korea. Seven hundred and eleven patients with bladder (269), prostate (300) or renal cancers (142) were selected to answer a self-administered questionnaire on CAM, which were then analyzed. Results: Among 711 patients with urological malignancies, 279 (39.2%) had been treated with at least one type of CAM, in addition to conventional Western treatment. The cancer patients treated with radiation therapy or immunotherapy were more likely to employ CAM than those using other therapies. Age, gender, cancer type, occupations, religions, level of education and disease status (stable or progressive) were not associated with the prevalence of CAM. 44.3% of CAM users wanted to discuss CAM techniques with their doctors, but only 24.8% received an explanation of there use. Conclusions: CAM is used by a large number of patients with urological malignancies, particularly in those undergoing radiation therapy or immunotherapy. Urologists need to have an accurate knowledge and apprehension of CAM. The possible effects and side effects should be defined, with appropriate guidelines recommended for patients with a urological malignancy.

Original languageEnglish
Pages (from-to)620-624
Number of pages5
JournalKorean Journal of Urology
Volume47
Issue number6
Publication statusPublished - 2006 Jun 1

Fingerprint

Complementary Therapies
Neoplasms
Kidney Neoplasms
Immunotherapy
Prostatic Neoplasms
Radiotherapy

Keywords

  • Alternative medicine
  • Bladder cancer
  • Prevalence
  • Prostate cancer
  • Renal cancer

ASJC Scopus subject areas

  • Urology

Cite this

Kim, C. S., Park, S., Lee, S. B., Lee, J. M., Chung, H., Chung, M. K., ... Kim, B. W. (2006). The use of complementary and alternative medicine in patients with a urological malignancy. Korean Journal of Urology, 47(6), 620-624.

The use of complementary and alternative medicine in patients with a urological malignancy. / Kim, Choung Soo; Park, Sungchan; Lee, Sang Bok; Lee, Jung Min; Chung, Han; Chung, Moon Kee; Yoon, Duck Ki; Cheon, Jun; Kim, Wun Jae; Chung, Byung Ha; Hong, Sung Joon; Song, Jae Mann; Chang, Sung Goo; Choi, Han Yong; Rim, Joung Sik; Cho, Yong Hyun; Moon, Kyung Hyun; Kim, Bup Wan; Kim, Bup Wan.

In: Korean Journal of Urology, Vol. 47, No. 6, 01.06.2006, p. 620-624.

Research output: Contribution to journalArticle

Kim, CS, Park, S, Lee, SB, Lee, JM, Chung, H, Chung, MK, Yoon, DK, Cheon, J, Kim, WJ, Chung, BH, Hong, SJ, Song, JM, Chang, SG, Choi, HY, Rim, JS, Cho, YH, Moon, KH, Kim, BW & Kim, BW 2006, 'The use of complementary and alternative medicine in patients with a urological malignancy', Korean Journal of Urology, vol. 47, no. 6, pp. 620-624.
Kim CS, Park S, Lee SB, Lee JM, Chung H, Chung MK et al. The use of complementary and alternative medicine in patients with a urological malignancy. Korean Journal of Urology. 2006 Jun 1;47(6):620-624.
Kim, Choung Soo ; Park, Sungchan ; Lee, Sang Bok ; Lee, Jung Min ; Chung, Han ; Chung, Moon Kee ; Yoon, Duck Ki ; Cheon, Jun ; Kim, Wun Jae ; Chung, Byung Ha ; Hong, Sung Joon ; Song, Jae Mann ; Chang, Sung Goo ; Choi, Han Yong ; Rim, Joung Sik ; Cho, Yong Hyun ; Moon, Kyung Hyun ; Kim, Bup Wan ; Kim, Bup Wan. / The use of complementary and alternative medicine in patients with a urological malignancy. In: Korean Journal of Urology. 2006 ; Vol. 47, No. 6. pp. 620-624.
@article{985fb8248d064291bda33dc8e4ebb9bd,
title = "The use of complementary and alternative medicine in patients with a urological malignancy",
abstract = "Purpose: The use of complementary and alternative medicine (CAM) is very common among patients with a urological malignancy. We assessed the prevalence and patterns of use of complementary therapies among patients with bladder, prostate and renal cancers. Materials and Methods: Between May and July 2004, we conducted a survey to assess the use of CAM at 13 outpatient clinics in Korea. Seven hundred and eleven patients with bladder (269), prostate (300) or renal cancers (142) were selected to answer a self-administered questionnaire on CAM, which were then analyzed. Results: Among 711 patients with urological malignancies, 279 (39.2{\%}) had been treated with at least one type of CAM, in addition to conventional Western treatment. The cancer patients treated with radiation therapy or immunotherapy were more likely to employ CAM than those using other therapies. Age, gender, cancer type, occupations, religions, level of education and disease status (stable or progressive) were not associated with the prevalence of CAM. 44.3{\%} of CAM users wanted to discuss CAM techniques with their doctors, but only 24.8{\%} received an explanation of there use. Conclusions: CAM is used by a large number of patients with urological malignancies, particularly in those undergoing radiation therapy or immunotherapy. Urologists need to have an accurate knowledge and apprehension of CAM. The possible effects and side effects should be defined, with appropriate guidelines recommended for patients with a urological malignancy.",
keywords = "Alternative medicine, Bladder cancer, Prevalence, Prostate cancer, Renal cancer",
author = "Kim, {Choung Soo} and Sungchan Park and Lee, {Sang Bok} and Lee, {Jung Min} and Han Chung and Chung, {Moon Kee} and Yoon, {Duck Ki} and Jun Cheon and Kim, {Wun Jae} and Chung, {Byung Ha} and Hong, {Sung Joon} and Song, {Jae Mann} and Chang, {Sung Goo} and Choi, {Han Yong} and Rim, {Joung Sik} and Cho, {Yong Hyun} and Moon, {Kyung Hyun} and Kim, {Bup Wan} and Kim, {Bup Wan}",
year = "2006",
month = "6",
day = "1",
language = "English",
volume = "47",
pages = "620--624",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "6",

}

TY - JOUR

T1 - The use of complementary and alternative medicine in patients with a urological malignancy

AU - Kim, Choung Soo

AU - Park, Sungchan

AU - Lee, Sang Bok

AU - Lee, Jung Min

AU - Chung, Han

AU - Chung, Moon Kee

AU - Yoon, Duck Ki

AU - Cheon, Jun

AU - Kim, Wun Jae

AU - Chung, Byung Ha

AU - Hong, Sung Joon

AU - Song, Jae Mann

AU - Chang, Sung Goo

AU - Choi, Han Yong

AU - Rim, Joung Sik

AU - Cho, Yong Hyun

AU - Moon, Kyung Hyun

AU - Kim, Bup Wan

AU - Kim, Bup Wan

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Purpose: The use of complementary and alternative medicine (CAM) is very common among patients with a urological malignancy. We assessed the prevalence and patterns of use of complementary therapies among patients with bladder, prostate and renal cancers. Materials and Methods: Between May and July 2004, we conducted a survey to assess the use of CAM at 13 outpatient clinics in Korea. Seven hundred and eleven patients with bladder (269), prostate (300) or renal cancers (142) were selected to answer a self-administered questionnaire on CAM, which were then analyzed. Results: Among 711 patients with urological malignancies, 279 (39.2%) had been treated with at least one type of CAM, in addition to conventional Western treatment. The cancer patients treated with radiation therapy or immunotherapy were more likely to employ CAM than those using other therapies. Age, gender, cancer type, occupations, religions, level of education and disease status (stable or progressive) were not associated with the prevalence of CAM. 44.3% of CAM users wanted to discuss CAM techniques with their doctors, but only 24.8% received an explanation of there use. Conclusions: CAM is used by a large number of patients with urological malignancies, particularly in those undergoing radiation therapy or immunotherapy. Urologists need to have an accurate knowledge and apprehension of CAM. The possible effects and side effects should be defined, with appropriate guidelines recommended for patients with a urological malignancy.

AB - Purpose: The use of complementary and alternative medicine (CAM) is very common among patients with a urological malignancy. We assessed the prevalence and patterns of use of complementary therapies among patients with bladder, prostate and renal cancers. Materials and Methods: Between May and July 2004, we conducted a survey to assess the use of CAM at 13 outpatient clinics in Korea. Seven hundred and eleven patients with bladder (269), prostate (300) or renal cancers (142) were selected to answer a self-administered questionnaire on CAM, which were then analyzed. Results: Among 711 patients with urological malignancies, 279 (39.2%) had been treated with at least one type of CAM, in addition to conventional Western treatment. The cancer patients treated with radiation therapy or immunotherapy were more likely to employ CAM than those using other therapies. Age, gender, cancer type, occupations, religions, level of education and disease status (stable or progressive) were not associated with the prevalence of CAM. 44.3% of CAM users wanted to discuss CAM techniques with their doctors, but only 24.8% received an explanation of there use. Conclusions: CAM is used by a large number of patients with urological malignancies, particularly in those undergoing radiation therapy or immunotherapy. Urologists need to have an accurate knowledge and apprehension of CAM. The possible effects and side effects should be defined, with appropriate guidelines recommended for patients with a urological malignancy.

KW - Alternative medicine

KW - Bladder cancer

KW - Prevalence

KW - Prostate cancer

KW - Renal cancer

UR - http://www.scopus.com/inward/record.url?scp=33748476792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748476792&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 620

EP - 624

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 6

ER -